ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,242,000 | -65.8% | 13,030 | -75.1% | 0.02% | -62.5% |
| Q2 2021 | $6,562,000 | -67.5% | 52,294 | -64.9% | 0.05% | -68.6% |
| Q1 2021 | $20,194,000 | -28.1% | 148,912 | -32.2% | 0.15% | -26.4% |
| Q4 2020 | $28,093,000 | +77.0% | 219,581 | +55.7% | 0.21% | +49.6% |
| Q3 2020 | $15,868,000 | +330.1% | 141,012 | +264.1% | 0.14% | +321.2% |
| Q2 2020 | $3,689,000 | +5.9% | 38,724 | -0.1% | 0.03% | -15.4% |
| Q1 2020 | $3,485,000 | – | 38,775 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |